Further evidence for the existence of a specific process for the membrane transport of anandamide.
D000581:Amidohydrolases / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism* / Q000494:pharmacology; D001692:Biological Transport; D001923:Brain Chemistry; D002352:Carrier Proteins / Q000378:metabolism*; D045744:Cell Line, Tumor / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D063388:Endocannabinoids; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005727:Ganglia, Spinal / Q000166:cytology; D006801:Humans; D007668:Kidney / Q000166:cytology; D015471:Leukemia, Basophilic, Acute / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009363:Neoplasm Proteins / Q000378:metabolism; D063065:Organophosphonates / Q000494:pharmacology; D053284:Polyunsaturated Alkamides; D051381:Rats; D013574:Synaptosomes / Q000378:metabolism; D019284:Thapsigargin / Q000494:pharmacology; D000099252:Fatty Acid Amide Hydrolases
D000581:Amidohydrolases; D001095:Arachidonic Acids; D002352:Carrier Proteins; D063388:Endocannabinoids; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D063065:Organophosphonates; D053284:Polyunsaturated Alkamides; D019284:Thapsigargin; D000099252:Fatty Acid Amide Hydrolases; C104810:methyl arachidonylfluorophosphonate; C078814:anandamide